BEDFORD, Mass., November 8, 2018 – Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, hosted an educational webinar with the National PKU Alliance to describe the opportunity for gene therapy and gene editing to treat and potentially cure PKU. The webcast replay is available at https://youtu.be/WemExU7d9pw.